Entity Details

Primary name PADI4_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9UM07
EntryNamePADI4_HUMAN
FullNameProtein-arginine deiminase type-4
TaxID9606
Evidenceevidence at protein level
Length663
SequenceStatuscomplete
DateCreated2001-01-11
DateModified2021-06-02

Ontological Relatives

GenesPADI4

GO terms

Show/Hide Table
GOName
GO:0004668 protein-arginine deiminase activity
GO:0005509 calcium ion binding
GO:0005634 nucleus
GO:0005654 nucleoplasm
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0006325 chromatin organization
GO:0006334 nucleosome assembly
GO:0006338 chromatin remodeling
GO:0006464 cellular protein modification process
GO:0018101 protein citrullination
GO:0019827 stem cell population maintenance
GO:0032991 protein-containing complex
GO:0034618 arginine binding
GO:0036413 histone H3-R26 citrullination
GO:0036414 histone citrullination
GO:0042802 identical protein binding
GO:0045087 innate immune response

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm
Cytoplasmic granule
Nucleus

Domains

Show/Hide Table
DomainNameCategoryType
IPR004303 Protein-arginine deiminaseFamilyFamily
IPR008972 CupredoxinFamilyHomologous superfamily
IPR013530 Protein-arginine deiminase, C-terminalDomainDomain
IPR013732 Protein-arginine deiminase (PAD), N-terminalDomainDomain
IPR013733 Protein-arginine deiminase (PAD), central domainDomainDomain
IPR036556 Protein-arginine deiminase, central domain superfamilyFamilyHomologous superfamily
IPR038685 PAD, N-terminal domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
180300 OMIMRheumatoid arthritis (RA)An inflammatory disease with autoimmune features and a complex genetic component. It primarily affects the joints and is characterized by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. The gene represented in this entry may be involved in disease pathogenesis. The association to rheumatoid arthritis was initially thought to result from increased citrullination of target proteins (PubMed:12833157). However, variants that have been associated to rheumatoid arthritis (Ser-55, Ala-82 and Ala-112) do not affect the catalytic activity or the citrullination activity of PADI4, suggesting that these variants may affect the mRNA stability rather than the protein (PubMed:21245532).

Drugs

Show/Hide Table
DrugNameSourceType
DB00155 CitrullineDrugbanksmall molecule
DB00207 AzithromycinDrugbanksmall molecule
DB00759 TetracyclineDrugbanksmall molecule
DB01082 StreptomycinDrugbanksmall molecule
DB07449 N-[(1S)-1-(aminocarbonyl)-4-(ethanimidoylamino)butyl]benzamideDrugbanksmall molecule